Long-Term Cardiac Sequelae in Patients Referred into a Diagnostic Post-COVID-19 Pathway: The Different Impacts on the Right and Left Ventricles.
SARS-CoV-2
biventricular dysfunction
cardiac involvement
echocardiography
long-COVID-19
pulmonary hypertension
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
06 Nov 2021
06 Nov 2021
Historique:
received:
07
09
2021
revised:
29
10
2021
accepted:
03
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
Most patients who had COVID-19 are still symptomatic after many months post infection, but the long-term outcomes are not yet well defined. The aim of our prospective/retrospective study was to define the cardiac sequelae of COVID-19 infection. This monocentric cohort study included 160 consecutive patients who had been discharged from the ward or from the outpatient clinic after a diagnosis of COVID-19 and subsequently referred for a follow-up visit. Clinical features' data about the acute phase along with information about the follow-up visit, including ECG and Echocardiographic parameters, were recorded. At an average follow-up of 5 months, echocardiography showed morpho-functional characteristics of both right (RV) and left (LV) ventricles, such as RV dilation, increased pressure in the pulmonary circulation, and bi-ventricular systolic-diastolic dysfunction. When examined using multivariate analysis, independent of age, sex, and co-morbidities, RV and LV changes were significantly associated with chest High-Resolution computed tomography score and hemodynamic Instability (HI), and with C-reactive protein, respectively. Our results suggest that COVID-19 may impact RV and LV differently. Notably, the extent of the pneumonia and HI may affect RV, whereas the inflammatory status may influence LV. A long-term follow-up is warranted to refine and customize the most appropriate therapeutic strategies.
Identifiants
pubmed: 34829406
pii: diagnostics11112059
doi: 10.3390/diagnostics11112059
pmc: PMC8623572
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Circ Res. 2020 May 8;126(10):1443-1455
pubmed: 32252591
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
Heart. 2020 Sep;106(17):1324-1331
pubmed: 32675217
Int J Cardiovasc Imaging. 2021 Jan;37(1):135-144
pubmed: 32803484
N Engl J Med. 2020 Jun 18;382(25):2478-2480
pubmed: 32302081
Thorax. 2021 Apr;76(4):405-407
pubmed: 33273028
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Circulation. 2020 Jul 28;142(4):342-353
pubmed: 32469253
JACC Case Rep. 2020 Jul 15;2(9):1414-1418
pubmed: 32835287
Eur Heart J. 2020 May 14;41(19):1861-1862
pubmed: 32267502
Lancet Reg Health Eur. 2021 Jul;6:100122
pubmed: 34027514
J Am Coll Cardiol. 2020 Oct 27;76(17):1965-1977
pubmed: 33092732
Eur J Heart Fail. 2020 May;22(5):911-915
pubmed: 32275347
JACC Basic Transl Sci. 2020 Apr 10;5(5):518-536
pubmed: 32292848
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687
pubmed: 32352535
Eur Heart J. 2020 Jun 7;41(22):2070-2079
pubmed: 32391877
JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
Echocardiography. 2020 Oct;37(10):1551-1556
pubmed: 32949015
Eur Respir J. 2018 Jan 31;51(2):
pubmed: 29386335
Int J Chron Obstruct Pulmon Dis. 2016 May 13;11:1015-22
pubmed: 27257378
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
J Am Soc Echocardiogr. 2009 Feb;22(2):107-33
pubmed: 19187853
Respir Care. 2019 Jun;64(6):617-628
pubmed: 31110031
Eur Heart J. 2020 Oct 14;41(39):3827-3835
pubmed: 32968776
JACC Cardiovasc Imaging. 2020 Nov;13(11):2287-2299
pubmed: 32654963
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Pulm Circ. 2020 Jul 2;10(3):2045894020936660
pubmed: 32655856
Heart. 2020 Aug;106(15):1127-1131
pubmed: 32499236
High Blood Press Cardiovasc Prev. 2021 Sep;28(5):439-445
pubmed: 34173942
ERJ Open Res. 2020 Oct 26;6(4):
pubmed: 33257910